Overexpression of platelet-derived growth factor receptor alpha in breast cancer is associated with tumour progression
about
Characterization of platelet-derived growth factor-A expression in mouse tissues using a lacZ knock-in approachRepression of SHP-1 expression by p53 leads to trkA tyrosine phosphorylation and suppression of breast cancer cell proliferationMesenchymal Stem Cells Induce Directional Migration of Invasive Breast Cancer Cells through TGF-βn-Butyl benzyl phthalate promotes breast cancer progression by inducing expression of lymphoid enhancer factor 1Circulating tumor cells: application as a biomarker for molecular characterization and predictor of survival in an all-comer solid tumor phase I clinical studySPARSE INTEGRATIVE CLUSTERING OF MULTIPLE OMICS DATA SETS.Biological processes, properties and molecular wiring diagrams of candidate low-penetrance breast cancer susceptibility genes.Molecular characterization of EGFR, PDGFRA and VEGFR2 in cervical adenosquamous carcinoma.Biologic effects of platelet-derived growth factor receptor α blockade in uterine cancer.In vitro effects of imatinib mesylate on radiosensitivity and chemosensitivity of breast cancer cells.Cancer gene panel analysis of cultured circulating tumor cells and primary tumor tissue from patients with breast cancer.The alpha-receptor for platelet-derived growth factor confers bone-metastatic potential to prostate cancer cells by ligand- and dimerization-independent mechanisms.Transcriptional activation of the Axl and PDGFR-α by c-Met through a ras- and Src-independent mechanism in human bladder cancer.The three receptor tyrosine kinases c-KIT, VEGFR2 and PDGFRα, closely spaced at 4q12, show increased protein expression in triple-negative breast cancer.Reduced ING1 levels in breast cancer promotes metastasisOptical fiber-based in vivo quantification of growth factor receptors.An improved syngeneic orthotopic murine model of human breast cancer progressionTargeting the PDGF signaling pathway in tumor treatmentA new mouse model for the study of human breast cancer metastasis.Phase I study of olaratumab in Japanese patients with advanced solid tumors.Expression of platelet derived growth factor family members and the potential role of imatinib mesylate for cervical cancer.Genome-wide analysis of loss of heterozygosity in breast infiltrating ductal carcinoma distant normal tissue highlights arm specific enrichment and expansion across tumor stages.Targeting signal transduction pathways in metastatic breast cancer: a comprehensive review.Effect of targeted agents on the endocrine response of breast cancer in the neoadjuvant setting: a systematic review.Mammary tumors that become independent of the type I insulin-like growth factor receptor express elevated levels of platelet-derived growth factor receptors.The c-MET Network as Novel Prognostic Marker for Predicting Bladder Cancer Patients with an Increased Risk of Developing Aggressive Disease.Effect of ulinastatin on growth inhibition, apoptosis of breast carcinoma cells is related to a decrease in signal conduction of JNk-2 and NF-κB.FoxM1 promotes breast tumorigenesis by activating PDGF-A and forming a positive feedback loop with the PDGF/AKT signaling pathway.Platelet-derived growth factor-C (PDGF-C) activation by serine proteases: implications for breast cancer progressionPrimary breast cancer cell culture yields intra-tumor heterogeneous subpopulations expressing exclusive patterns of receptor tyrosine kinases.Clinical trials update: endocrine and biological therapy combinations in the treatment of breast cancer.Inhibition of cancer cell growth by ruthenium complexesEmerging therapeutic targets in metastatic progression: A focus on breast cancer.Bypassing cellular EGF receptor dependence through epithelial-to-mesenchymal-like transitionsCarnitine palmitoyl transferase-1A (CPT1A): a new tumor specific target in human breast cancer.Prognostic significance of stromal platelet-derived growth factor beta-receptor expression in human breast cancer.Up-regulation of miR-21 by HER2/neu signaling promotes cell invasion.Imatinib mesylate (Gleevec) in advanced breast cancer-expressing C-Kit or PDGFR-beta: clinical activity and biological correlationsExpression, mutation and copy number analysis of platelet-derived growth factor receptor A (PDGFRA) and its ligand PDGFA in gliomas.One Step Assembly of Thin Films of Carbon Nanotubes on Screen Printed Interface for Electrochemical Aptasensing of Breast Cancer Biomarker.
P2860
Q21089666-1CB32A7B-456D-49D8-A62A-AD7E3EDFC8BCQ24315911-232C7AE7-65BF-4F4D-9AFF-1CFD55235D47Q27305351-8132CC8E-5033-4F7B-B3CF-F021D7B53464Q28482126-F44A3138-1B69-45DF-8252-53FA67E19611Q28535476-57787408-3ECC-4E9B-8B00-E023BBBC45B5Q30768936-136B9915-DDE3-4AD0-89BD-BD15EB8A1977Q33394388-E4DE59C2-883F-4742-B732-1E7A2D561BA7Q33475963-FF532FE7-BC86-4E14-B4C4-98BDD51FE66FQ33625089-AF696B4F-F3C4-4F8D-AB74-4A897A47630DQ33651783-A29F16E0-D403-42C3-B9FB-A04DED276667Q33751043-71546996-83BB-4E77-B2F1-24536B3D8D5CQ33874232-C82E0A75-86E7-4C6C-96FD-92B05A082EF6Q33874421-AFBAA49E-2897-4AEC-903C-A4F24992845BQ33903662-5C229CE4-5584-4A79-ABEE-B118CE24AC4BQ34100927-A44A3FEF-AEA5-4F9C-82D8-3A9433D7484FQ34226408-0FF99C57-8FDA-4952-A22C-412492E1E0CDQ34250295-ABB81731-2AC6-4513-BBB5-262995D152B9Q34393461-FD8877A2-9755-479F-8E42-79C9520FDD4AQ34464714-0730AB5A-F462-4DCE-848D-D2DBAF79242EQ35051852-0729E70B-D6D7-4D04-85BA-E46E001E5E01Q35082777-ACEBA427-8B2D-4F7A-B8B8-C2CA6D055378Q35153040-CFDBD701-E7F8-48C7-A43F-32F48C7876ECQ35583942-8AB3F42D-8C51-4247-800A-2072E74AB910Q35631641-7169DEAC-1505-4816-96D1-6FB862425CBCQ35661710-D13F0BF6-A89F-43BD-AD7B-00B38D83B157Q35726091-83E4A4B8-2676-4226-9655-A1DD7EBAEF85Q35744987-59B76633-27EC-49F1-A2D6-459D6A09556CQ35793788-668BF6A6-BFB9-44EF-BD8F-6177C48EB98AQ35929823-8A6204AC-384E-4E56-81C2-FE9B1B2336EDQ36137401-9185BF58-EA85-4BD9-97A7-9E3975521CD3Q36458731-F6C03A09-B9A2-4F57-9444-D665F8AFCB27Q36574799-9B83629C-B2BF-434E-939A-8046EEAE13E8Q36854062-A8596599-4FA9-4498-9923-06C1E1C3006AQ37072581-748FAB2E-826D-4BF3-BAB7-41041F9C69A8Q37190231-ADD3218F-5488-4845-95FA-01FCAABF08CFQ37257191-9D88B70F-697F-426A-89F6-37720F54104AQ37258559-89E1634B-B077-452B-95E3-F2159AB4C0D2Q37326191-3F2E7F04-C3BB-4405-931F-B3978C47666CQ37345320-36AE668D-4479-4027-A9FD-39223C13DDFBQ37380703-A800E735-934D-4A98-BA3B-7A6EFD9DA837
P2860
Overexpression of platelet-derived growth factor receptor alpha in breast cancer is associated with tumour progression
description
2005 nî lūn-bûn
@nan
2005 թուականին հրատարակուած գիտական յօդուած
@hyw
2005 թվականին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Overexpression of platelet-der ...... ciated with tumour progression
@ast
Overexpression of platelet-der ...... ciated with tumour progression
@en
Overexpression of platelet-der ...... ciated with tumour progression
@nl
type
label
Overexpression of platelet-der ...... ciated with tumour progression
@ast
Overexpression of platelet-der ...... ciated with tumour progression
@en
Overexpression of platelet-der ...... ciated with tumour progression
@nl
prefLabel
Overexpression of platelet-der ...... ciated with tumour progression
@ast
Overexpression of platelet-der ...... ciated with tumour progression
@en
Overexpression of platelet-der ...... ciated with tumour progression
@nl
P2093
P2860
P3181
P356
P1476
Overexpression of platelet-der ...... ciated with tumour progression
@en
P2093
Albino Martins
Fernanda Milanezi
Fernando Schmitt
Inês Carvalho
Rui M Reis
P2860
P2888
P304
P3181
P356
10.1186/BCR1304
P407
P577
2005-01-01T00:00:00Z
P5875
P6179
1017326983